Likewise, the incidence of ketoacidosis was comparable: 0.6% vs 0.5% (with SGLT2i) and 0.2% vs 0.2% (without SGLT2i)
Drug-Drug Interactions: Semanat 1mg (4mg/3ml) Injection 1's potentially interacts with certain medications used to treat certain cancers (e.g., bexarotene, capivasertib), certain general anaesthetics (e.g., desflurane, enflurane, etomidate, fospropofol, halothane, isoflurane, ketamine), antibiotics (e.g., gatifloxacin), certain insulin or sulfonylureas (e.g., glimepiride, glyburide) and certain GLP1 receptor agonists or similar weight-loss medications (e.g., liraglutide, tirzepatide)
Inadequate glycaemic control alongside continued hunger requires prompt attention
If you have questions about a specific order, contact our Customer Support with your order number